Ginsenoside compound K suppresses tumour growth in the <scp>22Rv1</scp> xenograft model and inhibits androgenic responses via the transcriptional mechanism in human prostate cancer cells-Reference-Cited by-同舟云学术

Ginsenoside compound K suppresses tumour growth in the 22Rv1 xenograft model and inhibits androgenic responses via the transcriptional mechanism in human prostate cancer cells

Published:2022-11-16 Issue:7 Volume:290 Page:1840-1854
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:The FEBS Journal

Author:

Jiang Mingyue¹,Sun You¹,Song Kyung¹²³⁴^ORCID

Affiliation:

1. Department of Herbal Resources, Professional Graduate School of Oriental Medicine Wonkwang University Iksan Korea

2. Department of Pharmacy, College of Pharmacy Wonkwang University Iksan Korea

3. Institute of Pharmaceutical Research and Development Wonkwang University Iksan Korea

4. Integrated Omics Institute Wonkwang University Iksan Korea

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.16676

Reference42 articles.

1. Trends in Prostate Cancer in the United States

2. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion

3. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

4. The mutational landscape of lethal castration-resistant prostate cancer

5. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic anticancer effects of ginsenoside CK and gefitinib against gefitinib-resistant NSCLC by regulating the balance of angiogenic factors through HIF-1α/VEGF;Toxicology and Applied Pharmacology;2024-05

2. Nanodelivery System of Traditional Chinese Medicine Bioactive Compounds: Application in the Treatment of Prostate Cancer;Phytomedicine;2024-03

3. Ginsenoside – a promising natural active ingredient with steroidal hormone activity;Food & Function;2024

4. Androgen receptor and hyaluronan-mediated motility receptor as new molecular targets of baicalein: new molecular mechanisms for its anticancer properties;Archives of Pharmacal Research;2023-08